REGISTERED NUMBER: 14826248 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 March 2025

for

Medspark Limited

Page

Company Information

1

Balance Sheet

2

DIRECTORS:

A J Porteous

Mrs J Seddon-Porteous

REGISTERED OFFICE:

B1 Vantage Park

Old Gloucester Road

Hambrook

Bristol

BS16 1GW

REGISTERED NUMBER:

14826248 (England and Wales)

ACCOUNTANTS:

Northcott Accountancy Limited

Chartered Accountants

134 Johnson Road

Bristol

BS16 7JP

FIXED ASSETS

625

-

CURRENT ASSETS

62,464

14,077

CREDITORS

Amounts falling due within one year

(12,356

)

(3,626

)

NET CURRENT ASSETS

50,108

10,451

TOTAL ASSETS LESS CURRENT LIABILITIES

50,733

10,451

CAPITAL AND RESERVES

50,733

10,451

NOTE TO THE FINANCIAL STATEMENTS

1.	AVERAGE NUMBER OF EMPLOYEES INCLUDING DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 5 December 2025 and were signed on its behalf by:

A J Porteous - Director